Neurocrine Biosciences Inc (NBIX)

Neurocrine Biosciences Inc (NBIX) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $14.6B; returns 1 day -0.4%, 1 week +5.2%, 1 year -0.7%.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing treatments for neurological, endocrine, and neuropsychiatric disorders.

Groups NBIX belongs to

• Biotechnology
• Healthcare
• Biopharmaceutical
• Neuroscience
• Commercial Stage Biotech
• Neurological Disorders
• CNS Disorders
• Pharmaceuticals
• Endocrinology
• Rare Diseases
• R&D

NBIX financial model: income statement, cash flow and balance sheet